Abstract
Abstract First 100 words of main text: Solomon et al reporting for the Center for International Blood and Marrow Transplantation Research (CIBMTR) comparable outcomes in African American adults (18-70yrs) with a hematological malignancy (AML, ALL, MDS or NHL) following Treplete haploidentical stem cell transplantation (HaploSCT) with post HaploSCT cyclophosphamide vs unrelated umbilical cord blood transplantation (UCBT). The UCBT group included both single (>2.5 × 10 7 TNC/kg) and double (>1.5 × 10 7 TNC/unit) with a 1 or 2 HLA mismatch (low resolution typing at HLA A and B and allelelevel typing at DRB1) [1] . Solomon et al demonstrated a significant reduction in grade II-IV and III-IV acute graft versus host disease
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
